Medications

Gilead seeks FDA approval for remdesivir

(HealthDay)—Gilead Sciences has applied to the U.S. Food and Drug Administration for approval for its COVID-19 treatment, remdesivir. The antiviral drug will take the brand name Veklury, the company said.

Diseases, Conditions, Syndromes

Experts make weak recommendation for remdesivir in severe COVID-19

In The BMJ today, a panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued enrolment of patients into ongoing clinical trials of ...

Diseases, Conditions, Syndromes

Some hospitals in COVID-19 hotspots running short of remdesivir

(HealthDay)—Some U.S. hospitals in COVID-19 hotspots are running short of the antiviral drug remdesivir—the only drug authorized by the U.S. Food and Drug Administration to treat the disease—while hospitals in other ...

Medications

Remdesivir can save more lives where ICUs are overwhelmed

Amid news that the United States has bought up virtually the entire global supply of remdesivir, a new Boston University School of Public Health (BUSPH) study outlines how the drug could save lives in countries with less ...

page 1 from 4